
Cadovel 3.5mg Injection
Marketer
Atisa life Sciences Pvt Ltd
Salt Composition
Bortezomib (3.5mg)
Overview Cadovel 3.5mg Injection
Carfilzomib 3.5mg injection treats multiple myeloma and mantle cell lymphoma by inhibiting cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined individually by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include tiredness, nausea, vomiting, and appetite loss. Increased fluid intake is often recommended. Operating machinery or driving should be avoided due to potential drowsiness and dizziness. This medication can reduce blood cell counts (red and white blood cells), increasing infection risk. Regular blood tests monitoring blood cell levels, along with heart, liver function, and uric acid, are necessary. Pre-existing liver, kidney, heart disease, or bleeding disorders should be disclosed to your doctor before commencing treatment. Report cognitive changes like memory loss or impaired thinking immediately. Inform your healthcare provider of all other medications you're taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners throughout treatment.
Primary Ingredients of Cadovel 3.5mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Cadovel 3.5mg Injection
Myeloma and mantle cell lymphoma
Major Benefits of Cadovel 3.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cadovel 3.5mg Injection:
- Low blood platelets
- Fatigue
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Psychiatric disturbances
- Nausea
- Vomiting
- Loss of appetite
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased appetite
- Decreased white blood cell count (neutrophils)
- Constipation
How to use Cadovel 3.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Cadovel 3.5mg Injection works:
Cadovel 3.5mg Injection is an anticancer agent that inhibits the cellular degradation of proteins. This protein accumulation within cancer cells ultimately triggers their demise.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Cadovel 3.5mg Injection and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering Cadovel 3.5mg Injection during pregnancy is contraindicated due to confirmed harm to the fetus. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the hazards. Seek medical advice.
Breast feedingUNSAFE
Administration of Cadovel 3.5mg Injection is contraindicated while breastfeeding due to potential infant toxicity indicated by available data.
DrivingUNSAFE
Administering Cadovel 3.5mg Injection may induce adverse reactions impacting driving capabilities. These potential side effects include drowsiness, vertigo, syncope, or visual disturbances, all of which could impair driving ability.
KidneyCAUTION
For individuals with severe kidney impairment, administration of Cadovel 3.5mg Injection requires careful consideration. A modified dosage of Cadovel 3.5mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
For individuals with hepatic impairment, administration of Cadovel 3.5mg Injection requires careful monitoring. Dosage modification of Cadovel 3.5mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Cadovel 3.5mg Injection :
Omit a Cadovel 3.5mg Injection dose? Seek your physician's advice.
Facts to Know About Cadovel 3.5mg Injection
| Label | Value |
|---|---|
| Chemical Category | Phenylalanine-Based Compounds |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
